NXP Fostering Patient Empowerment Through NFC-Enabled Self-Care

NXP Selfcare 820 x410

In recent years, specialty pharmaceuticals and other biotech products aimed at treating chronic diseases such as diabetes and chronic obstructive pulmonary disease have been on the rise. Concurrently, there has been an increased focus on self-care at home, with patients administering their own treatments, particularly injectable and inhalable drugs. Many of these self-administered drugs are supplied in connected drug-delivery devices, creating a valuable link between the patient and the medication, as well as between the healthcare provider and the patient.

Near Field Communication (NFC) technology, a short-range wireless technology, can be added to mechanical devices to create secure, easy-to-use patient experiences. For purely mechanical devices, passive or connected NFC tags, which can harvest energy from the NFC field generated by the reader (e.g., a smartphone), can add connectivity without requiring additional electronic components or a battery. Conversely, for devices already equipped with electronics and a power source, an NFC reader frontend or NFC controller can be integrated into the design.

Depending on the use case, patients may need to install a mobile app or use existing internet connectivity by tapping their smartphone to the device to launch a website that provides digital guidance. With a single tap, patients can check product authenticity, receive step-by-step application guidance, or maintain a digital regimen diary based on automated timestamps. A mobile app can perform simple data-processing tasks to display real-time information to the patient, or data can be sent to the cloud for more complex processing and analysis.

NFC can automate communication between a reusable drug-delivery device and a disposable drug container, such as a cartridge or pre-filled syringe. The device, equipped with an NFC reader, communicates directly with a passive NFC tag on the container. This NFC communication can verify the originality of the consumable, check the drug's expiration date, confirm the drug type and batch number, and read parameters that might require adjusting device settings. Additionally, the NFC reader can register dosage events, preventing consumable reuse. A delivery device can also provide sensor-based feedback to ensure medications are handled and dosed correctly in real time.

Studies from the World Health Organization (WHO) and others reveal that 50% of patients with chronic diseases are non-adherent to treatments, often missing doses, taking the wrong dose, or stopping treatment altogether. This is frequently due to a drug’s negative side effects, dose frequency, over-/under-dosing, or the usability of the delivery device. Connected devices can help patients better manage their conditions by providing immediate feedback during administration. Automated features can effortlessly capture key information such as injection dose, date, and time. Additionally, notifications can remind patients when their next dose is due or alert them when doses are missed. Collected data can be uploaded to a cloud-hosted service for complex data processing and shared with healthcare systems to keep clinicians informed.

It’s an unfortunate fact that counterfeit, adulterated, off-label, and diverted products have become increasingly widespread, to the point that the WHO describes counterfeits as “one of the urgent healthcare challenges of the decade.”

To reassure patients concerned about the security of their drug-delivery systems and prevent the use of wrong or fake products, manufacturers can implement authentication and authorization processes. Authentication verifies that a device or its medication is genuine, securing access to applications or data.

While identification validates serial numbers using online allowlists, NFC-based authentication performs enhanced checks based on an item’s NFC tag data and credentials, using secure cryptographic functions. Authorization can further verify attributes of each tag, ensuring rightful access to user data or the delivery system.

NXP Smart Technology Solutions

NXP offers well-matched Reader and Tag IC solutions to help customers design advanced, integrated systems that benefit from enhanced functionality, interoperability, and performance.

Our NFC authentication tags come with standard-based AES-128 cryptography. Popular tags include NTAG 424 DNA and NTAG 22x DNA (ISO 14443/Type 2 or 4 Tag) as well as ICODE DNA (ISO 15693/Type 5 Tag), supporting different operating distances and form-factor dimensions. Some tags support web-based dynamic NFC message authentication upon every NFC phone readout to prevent mass cloning. Others support a mutual authentication mechanism, ensuring only an authenticated reader can access sensitive tag data, protecting it against unauthorized access. Certain tags also come with enhanced status-sensing capability, measuring factors such as opening indication, fill level, or the completion of a mechanical function – even without a battery.

Our NTAG 5 (ISO 15693/T5T) connected NFC tags are versatile devices for use in or on systems with an electrical system interface to connect to an external sensor or microcontroller. In medical devices, our connected tags can help ensure a drug is within the right temperature window or control pressure in an inhalation device. They also support advanced memory-data protection with access rights.

All these NFC tags are supported by NXP’s latest single-chip NFC microcontroller, PN7642, which offers the highest integration level and the smallest footprint for adding NFC reader functionality, processing, and cryptographic security, even in small drug-delivery devices.

The Future of Connectivity in Healthcare

Connectivity will continue to play an important role in maximizing the quality of healthcare for patients, especially those with chronic conditions. NXP has become a key technology provider in the field of connected drug delivery devices, leveraging high-quality, reliable products and an extensive partner network.

 

Discover NXP's Innovations at MEDICA 2024
Visit NXP's Booth B22 at MEDICA 2024, November 11-14 in Düsseldorf, to explore semiconductor solutions for efficient, reliable, and safer medical IoT devices.


LEARN MORE

Related news articles

Latest News

Sorry, your filter selection returned no results.

We've updated our privacy policy. Please take a moment to review these changes. By clicking I Agree to Arrow Electronics Terms Of Use  and have read and understand the Privacy Policy and Cookie Policy.

Our website places cookies on your device to improve your experience and to improve our site. Read more about the cookies we use and how to disable them here. Cookies and tracking technologies may be used for marketing purposes.
By clicking “Accept”, you are consenting to placement of cookies on your device and to our use of tracking technologies. Click “Read More” below for more information and instructions on how to disable cookies and tracking technologies. While acceptance of cookies and tracking technologies is voluntary, disabling them may result in the website not working properly, and certain advertisements may be less relevant to you.
We respect your privacy. Read our privacy policy here